← SynDRA
EQUILIN
SynDRA canonical compound SYN0003798 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HSD17B1 |
|---|
| Mechanism of action | Estrogen receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- ESR1 AGONIST
- HSD17B1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ESR2
- SHBG
- ALDH1A1
- POLB
- TARDBP
- SMAD3
- SLCO1B3
- SLCO1B1
- SAMHD1
- RACGAP1
- PTH1R
- NFE2L2
- P4HB
- ATAD5
- KDM4E
- HSD17B7
- HSD11B2
- HSD11B1
- HDAC6
- GMNN
- CYP3A4
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AK1C4
- ALR
- SMAD2
- RGAP1
- PRGR
- NR1I2
- MDR1
- HXA9
- GNA15
- GLI3
- GCR
- ESRRA
- CP3A4
- CP2CJ
- CP2C9
- CP1A2
- ANDR
- TAAR1
Cross-references
Synonyms
- NSC-10971
- 7-Dehydroestrone
- Dihydroequilenin
- 3-HYDROXYESTRA-1,3,5(10),7-TETRAEN-17-ONE
- 1,3,5,7-Estratetraen-3-ol-17-one
- Equilin [USP]
- UNII-08O86EX0J4
- MLS000028624
- CHEBI:42309
- WKRLQDKEXYKHJB-HFTRVMKXSA-N
- 08O86EX0J4
- Equilin (USP)
- SMR000058656
- 3-hydroxy-estra-1,3,5(10),7tetraen-17-one
- Estra-1,3,5(10),7-tetraen-17-one,3-hydroxy-
- CCRIS 9074
- EINECS 207-488-6
- NSC 10971
- BRN 2624302
- (9S,13S,14S)-3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one
- Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-
- DTXCID5027433
- NSC10971
- RefChem:591016
- DTXCID90210237
- Equilin CRS
- CAS-474-86-2
- Prestwick_219
- Equilin (Standard)
- Opera_ID_780
- EQUILIN [MI]
- EQUILIN [MART.]
- Prestwick0_000850
- Prestwick1_000850
- Prestwick2_000850
- Prestwick3_000850
- EQUILIN [USP-RS]
- EQUILIN [WHO-DD]
Look up EQUILIN in the interactive SynDRA portal →